Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2002Arthritis & Rheumatism

Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy

View Full Paper
Ask AI
Bookmark
Share

Authors

FBFilip Van den BoschGhent University HospitalEKElli KruithofGhent University HospitalDBDominique BaetenRoche (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bosch et al. (2002) studied this question.

synapsesocial.com/papers/6a7d3aca86b21ee5f583d6cahttps://doi.org/10.1002/art.511
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis1995 · 691 citations
  2. 2Evaluation of Diagnostic Criteria for Ankylosing Spondylitis1984 · 5,768 citations
  3. 3Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study1999 · 316 citations